High-density lipoprotein and cardiovascular risk

PP Toth - Circulation, 2004 - Am Heart Assoc
1809 duction (which is both vasodilatory and antithrombotic), inhibits endothelial cell
apoptosis, decreases platelet aggregability, and inhibits LDL oxidation, among other …

[引用][C] High-density lipoprotein and cardiovascular risk

PP Toth - Circulation, 2004 - pubmed.ncbi.nlm.nih.gov

High-density lipoprotein and cardiovascular risk.

PP Toth - 2004 - cabidigitallibrary.org
Skip the header click to show the menu Menu Cart Login Login/Register Institutional Access
Access Options Enter words / phrases / DOI / ISBN / keywords / authors / etc Search Advanced …

[引用][C] High-density lipoprotein and cardiovascular risk

PP TOTH - Circulation (New York, NY), 2004 - pascal-francis.inist.fr
High-density lipoprotein and cardiovascular risk CNRS Inist Pascal-Francis CNRS Pascal
and Francis Bibliographic Databases Simple search Advanced search Search by …

[PDF][PDF] original

PP Toth - Circulation, 2004 - siicsalud.com
La enfermedad coronaria será la causa más frecuente de pérdidas DALY (incapacidad
ajustada por año de vida) en 2020 comparada con la quinta posición que ocupaba en 1991 …

[引用][C] High-density lipoprotein and cardiovascular risk.

PP Toth - Circulation, 2004 - europepmc.org
High-density lipoprotein and cardiovascular risk. - Abstract - Europe PMC Sign in | Create an
account https://orcid.org Europe PMC Menu About Tools Developers Help Contact us …

[引用][C] High-density lipoprotein and cardiovascular risk

PP TOTH - Circulation, 2004 - Lippincott Williams & Wilkins